Cabaletta Bio (CABA) Operating Leases (2022 - 2025)

Cabaletta Bio's Operating Leases history runs 4 years deep, the most recent figure standing at $580000.0 for Q2 2025.

• On a quarterly basis, Operating Leases changed N/A year-over-year to $580000.0 in Q2 2025; TTM through Jun 2025 was $580000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $2.4 million, up 63.51% from the prior year.
• Operating Leases retreated to $580000.0 in Q2 2025 per CABA's latest filing, from $1.5 million in the prior quarter.
• Across five years, Operating Leases topped out at $7.3 million in Q3 2024 and bottomed at $580000.0 in Q2 2025.
• The 4-year median for Operating Leases is $1.9 million (2023), against an average of $2.3 million.
• Biggest YoY gain for Operating Leases was 316.88% in 2024; the steepest drop was 69.29% in 2024.
• Year by year, Operating Leases stood at $3.0 million in 2022, then slumped by 50.73% to $1.5 million in 2023, then surged by 63.51% to $2.4 million in 2024, then plunged by 75.67% to $580000.0 in 2025.
• Per Business Quant, the three latest CABA Operating Leases figures stand at $580000.0 (Q2 2025), $1.5 million (Q1 2025), and $2.4 million (Q4 2024).